2 active not recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 2 |
Follow Radiation Therapy: new trials by email Literature Review of Radiation Therapy trials Research Report on Radiation Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pembrolizumab in Combination With Eftilagimod Alpha and Radiotherapy in Neoadjuvant Treatment of Patients With Soft Tissue Sarcoma - EFTISARC-NEO Trial Pembrolizumab, Eftilagimod alfa - Neoadjuvant, Immunotherapy | Phase 2 | Active not recruiting | Maria Sklodowska-Curie National Research Institute of Oncology | 40 | 2023-07-17 | 2025-12-08 |
| Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17) Paclitaxel, Carboplatin, Radiotherapy - Esophagus Cancer, Esophageal Squamous Cell Carcinoma | Phase 2 | Active not recruiting | Fudan University | 70 | 2020-05-30 | 2023-08-03 |
Esophageal Neoplasms (1) · Esophageal Squamous Cell Carcinoma (1) · Sarcoma (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Carcinoma (1) · Carcinoma, Squamous Cell (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Esophageal Diseases (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Head and Neck Neoplasms (1) · Neoplasms by Site (1) · Neoplasms, Connective and Soft Tissue (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Squamous Cell (1)
Carboplatin (1) · Paclitaxel (1) · Radiotherapy (1) · pembrolizumab (1)
Fudan University (1) · Maria Sklodowska-Curie National Research Institute of Oncology (1)
China (1) · Poland (1)
Katarzyna Kozak (1) · Kuaile Zhao (1)